Polyoxidony / Polyoksidoni 12 mg (10 and 49 similar items

Polyoxidony / Polyoksidoni 12 mg (10 suppositories * 12 mg) Indications • Treatment and prevention of infectious and inflammatory diseases (viral, bacterial and fungal etiology), in the stage of exacerbation and remission in adults and children over 1 year old. For the treatment of adults (in complex therapy): • acute and exacerbation of chronic recurrent infectious and inflammatory diseases of various localization, bacterial, viral and fungal etiology; • inflammatory diseases of the urogenital tract (urethritis, cystitis, pyelonephritis, prostatitis, salpingoophoritis, endometritis, colpitis, cervicitis, cervicosis, bacterial vaginosis); • various forms of pulmonary tuberculosis; • allergic diseases (including pollinosis, bronchial asthma, atopic dermatitis) complicated by recurrent bacterial, fungal and viral infections; • rheumatoid arthritis, complicated by recurrent bacterial, fungal and viral infections, on the background of long-term use of immunosuppressants; • to activate regenerative processes (fractures, burns, trophic ulcers); • in the complex therapy of oncological diseases during chemo and radiation therapy, to reduce the nephrotoxic and hepatotoxic effects of drugs. For prevention in adults (monotherapy): • recurrent and herpetic infections of the urogenital tract; • exacerbations of chronic foci of infections; • influenza and other acute respiratory infections in the pre-epidemic and epidemic period in immunocompromised individuals; • secondary immunodeficiency due to aging or exposure to adverse factors. For the treatment of children from 6 to 18 years old (in complex therapy): • acute and exacerbation of chronic recurrent infectious and inflammatory diseases of various localization, bacterial, viral and fungal etiology; • inflammatory diseases of the urogenital tract (urethritis, cystitis, pyelonephritis); • various forms of pulmonary tuberculosis; • allergic diseases (including pollinosis, bronchial asthma, atopic dermatitis) complicated by recurrent bacterial, fungal and viral infections; • to activate regenerative processes (fractures, burns, trophic ulcers); • in the complex therapy of oncological diseases during chemo and radiation therapy, to reduce the nephrotoxic and hepatotoxic effects of drugs. For prevention in children from 6 to 18 years of age (monotherapy): • recurrent and herpes infection of the urogenital tract; • exacerbations of chronic foci of infections; • influenza and other acute respiratory infections in the pre-epidemic and epidemic period in immunocompromised individuals. For the treatment of children from 1 to 6 years old (in complex therapy): • acute and exacerbation of chronic recurrent infectious and inflammatory diseases of various localization, bacterial, viral and fungal etiology; • inflammatory diseases of the urogenital tract (urethritis, cystitis, pyelonephritis); • various forms of pulmonary tuberculosis; • allergic diseases (including pollinosis, bronchial asthma, atopic dermatitis) complicated by recurrent bacterial, fungal and viral infections; • to activate regenerative proces (description exceeds maximum possible length)